D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$384M |
| 2 |
Apple
AAPL
|
+$377M |
| 3 |
PayPal
PYPL
|
+$368M |
| 4 |
Pfizer
PFE
|
+$339M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$461M |
| 4 |
Citigroup
C
|
+$361M |
| 5 |
Booking.com
BKNG
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.52% |
| 2 | Consumer Discretionary | 9.06% |
| 3 | Financials | 8.14% |
| 4 | Healthcare | 8% |
| 5 | Energy | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TUYA
3076
Tuya Inc
TUYA
$1.04B
| $2.13M | ﹤0.01% |
+719,086
| New | +$3.44M |
|
|
FRLAU
3077
DELISTED
Fortune Rise Acquisition Corporation Units
FRLAU
| $2.13M | ﹤0.01% |
209,666
-83,334
| -28% | -$842K |
|
3078
Zai Lab
ZLAB
$2.06B
| $2.12M | ﹤0.01% |
48,292
+460
| +1% | +$22.2K |
|
|
SPK
3079
DELISTED
SPK Acquisition Corp. Common Stock
SPK
| $2.12M | ﹤0.01% |
213,247
+100
| +0% | +$995 |
|
3080
Bright Horizons
BFAM
$4.1B
| $2.12M | ﹤0.01% |
15,995
-99,624
| -86% | -$12.9M |
|
3081
Clearway Energy Class C
CWEN
$4.94B
| $2.12M | ﹤0.01% |
58,064
-31,307
| -35% | -$1.07M |
|
3082
MacroGenics
MGNX
$240M
| $2.12M | ﹤0.01% |
240,598
+181,203
| +305% | +$2M |
|
|
PPLI
3083
People Inc
PPLI
$3.08B
| $2.12M | ﹤0.01% |
25,762
-118,483
| -82% | -$11.5M |
|
3084
Peapack-Gladstone Financial
PGC
$815M
| $2.12M | ﹤0.01% |
60,892
-14,620
| -19% | -$538K |
|
|
PRMW
3085
DELISTED
Primo Water Corporation
PRMW
| $2.11M | ﹤0.01% |
148,301
+69,569
| +88% | +$1.09M |
|
|
PBCT
3086
DELISTED
People's United Financial Inc
PBCT
| $2.11M | ﹤0.01% |
105,344
-6,755
| -6% | -$138K |
|
3087
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
| $2.1M | ﹤0.01% |
37,840
| – | – |
|
3088
CALL
Mid-America Apartment Communities
MAA
$15.5B
| $2.1M | ﹤0.01% |
10,000
-36,900
| -79% | -$7.73M |
|
|
3089
PUT
Mid-America Apartment Communities
MAA
$15.5B
| $2.1M | ﹤0.01% |
10,000
-11,500
| -53% | -$2.41M |
|
3090
Caribou Biosciences
CRBU
$150M
| $2.09M | ﹤0.01% |
228,027
+86,666
| +61% | +$913K |
|
3091
SSR Mining
SSRM
$5.54B
| $2.09M | ﹤0.01% |
+96,210
| New | +$1.81M |
|
3092
PUT
Penumbra
PEN
$12.6B
| $2.09M | ﹤0.01% |
9,400
-600
| -6% | -$133K |
|
3093
Vishay Precision Group
VPG
$1.17B
| $2.09M | ﹤0.01% |
64,932
-2,791
| -4% | -$90.5K |
|
3094
Deckers Outdoor
DECK
$13.6B
| $2.09M | ﹤0.01% |
45,726
-40,092
| -47% | -$1.99M |
|
|
CPTK
3095
DELISTED
Crown PropTech Acquisitions
CPTK
| $2.08M | ﹤0.01% |
211,023
-69,500
| -25% | -$686K |
|
|
VNET
3096
VNET Group
VNET
$2.08B
| $2.08M | ﹤0.01% |
357,501
+325,065
| +1,002% | +$2.5M |
|
3097
Agnico Eagle Mines
AEM
$75.4B
| $2.08M | ﹤0.01% |
33,938
-619,410
| -95% | -$33.5M |
|
|
VERV
3098
DELISTED
Verve Therapeutics
VERV
| $2.08M | ﹤0.01% |
91,006
+78,380
| +621% | +$2.24M |
|
3099
ACV Auctions
ACVA
$1.4B
| $2.08M | ﹤0.01% |
+140,170
| New | +$1.95M |
|
3100
Iovance Biotherapeutics
IOVA
$2.09B
| $2.08M | ﹤0.01% |
124,627
+52,590
| +73% | +$813K |
|
Similar funds
D.E. Shaw & Co's Q1 2022 Portfolio in Review
As of Q1 2022, D.E. Shaw & Co held 6,280 positions worth $107B, down 11% from $121B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
D.E. Shaw & Co withdrew a net $14.2B in Q1 2022, closing 805 positions and reducing 2,078 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.02B position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in Cenovus Energy worth $141M.
- D.E. Shaw & Co's largest Q1 2022 buy was Cenovus Energy: 8,428,527 shares worth $141M.
- D.E. Shaw & Co added most to Starbucks in Q1 2022, an estimated $384M increase.
- D.E. Shaw & Co's biggest Q1 2022 reduction was Netflix, cutting an estimated $461M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $1.02B.
- D.E. Shaw & Co's ten largest holdings make up 9.3% of its $107B portfolio in Q1 2022.
- D.E. Shaw & Co opened 934 new positions and closed 805 in Q1 2022.
- D.E. Shaw & Co's portfolio value fell 11% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.